Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 07:17 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » Buy: ACRS = MC$ 44 M /Cash $115 M / Phase 3 readout imminent



Reply
 
Thread Tools Search this Thread
Old 09-27-2019, 01:18 PM   Nav to Top  #11
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 252
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

New presentation
https://investor.aclaristx.com/stati...6-d7d9cb8c700e
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 09-30-2019, 09:48 AM   Nav to Top  #12
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 252
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Price $1.14 ...

Book Value $3.30 / Cash per Share $2.79 / 2+ years of Cash / 2 Approved Drugs / Another one with strong phase 3 results /Licensing Deals + Eskata approvalaround the corner = GREAT BUYING OPP
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-03-2019, 10:49 AM   Nav to Top  #13
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 252
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

What you get for the Market Cap of laughable $42 Million = you get $115 M of Cash or enough untill end 2021 / 2 Approved Drugs for which they own WW rights one of them acquired for $65 Million from Allergan / Another HUGE drug in Phase 3 with strong results in first P3 trial / and many other drugs in Phase 2 trials...the dropping stock markets created a mega opportunity here ...
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-04-2019, 02:55 PM   Nav to Top  #14
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 252
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Looks like major breakout is imminent guys

Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-07-2019, 09:27 AM   Nav to Top  #15
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 252
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Price $1.13 ...Market cap $45 Million ...Cash $115Million ...Book Value $3.30 ...Cash per Share $2.79 = MEGA STRONG BUY

UPCOMING BIG MILESTONES EXPECTED DURING Q4

Eskata approval could come this or next Week

A-101(common warts) final Phase 3 readout within 4-6 weeks

ATI-450 (Rheumatoid arthritis) Phase 1 results before year end

Partnership(s) for Eskata (approved), Rhofade (approved), A-101 (Phase 3) , ATI-502 (Phase 2) oral & topical could hit the wire anytime now .
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-10-2019, 10:04 AM   Nav to Top  #16
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 252
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

ACRS..Eskata approval likely next week guys , 10 months review timeline like in USA so approval should come next week


Price $1.17 ...Market cap $48 Million ...Cash $115Million ...Book Value $3.30 ...Cash per Share $2.79

Cipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada
https://cipher.investorroom.com/2018...-Health-Canada

Dec. 18, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) today announced that its New Drug Submission ("NDS") for A-101 40% topical solution ("A-101 40%") for the treatment of raised seborrheic keratoses ("SKs") has been accepted for review by Health Canada. Cipher acquired the exclusive Canadian rights to distribute and commercialize A-101 40% from Aclaris Therapeutics, Inc. (NASDAQ:ACRS) ("Aclaris") in April 2018.

A-101 40% is a U.S. Food and Drug Administration ("FDA")-approved product indicated for the treatment of raised SKs, which are commonly occurring non-cancerous skin growths that affect more than 9 million Canadian adults and can be an aesthetic skin concern. A-101 40% was approved by the FDA in December 2017 and is marketed by Aclaris in the U.S. under the tradename Eskata .
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-11-2019, 06:04 AM   Nav to Top  #17
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 252
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Great News out ...could hit $2 today...up 26% in pre mkt


Aclaris Therapeutics Announces Divestiture of RHOFADE®
Aclaris Therapeutics Announces Divestiture of RHOFADE® | Aclaris Therapeutics, Inc.
Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: ARDX (MC $155 M) FDA Decision on Sept 12 & Phase 3 readout this Quarter Biohero US Stock Picks 2 09-03-2019 01:22 PM
Strong Buy: TNXP (MC $32M) (Cash $34M) O/S 7.5 M / Phase 3 Data in 1H 2018 =More than just cheap Biohero US Stock Picks 6 01-23-2018 04:48 AM
Strong Buy: AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 Ongoing =TOP PICK Biohero US Stock Picks 25 01-18-2018 09:22 AM
Strong Buy: ARDM (MC $49 M / Cash $40 M) Phase 3 Results for Real Blockbuster in 2H 2016 = 1000% Biohero US Stock Picks 1 04-17-2016 11:06 PM
Strong Buy: BLUSF (MC $17 M) (Cash $16M ) Big Rare Disease Drug in Phase 3 Close to End = 1000% Biohero US Penny Stock Picks 0 01-28-2014 09:20 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On